Sensei Biotherapeutics, Inc.
SNSE
$0.3857
-$0.0192-4.74%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.57% | 23.43% | 34.37% | 31.16% | 29.82% |
| Total Depreciation and Amortization | -2.15% | -3.86% | -4.56% | -3.43% | 0.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -7.97% | -15.00% | -18.08% | -19.15% | -29.83% |
| Change in Net Operating Assets | 88.71% | 65.22% | -362.20% | -68.73% | -529.56% |
| Cash from Operations | 22.96% | 29.33% | 35.51% | 30.26% | 17.94% |
| Capital Expenditure | 18.89% | 18.89% | 66.05% | 85.43% | 43.93% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -100.00% | 554.17% | 1,006.67% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -41.22% | -26.42% | -36.98% | 3.17% | -23.54% |
| Cash from Investing | -41.58% | -26.71% | -36.96% | 4.50% | -23.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -6.57% | -7.82% | -9.93% | -13.49% | -20.99% |
| Issuance of Common Stock | -29.17% | -54.76% | -54.76% | -46.67% | -85.96% |
| Repurchase of Common Stock | 99.90% | 97.43% | 66.86% | -13,576.32% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 92.96% | 90.58% | 60.52% | -1,564.67% | -3,793.03% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 36.94% | 7,378.50% | 409.17% | 565.20% | -144.98% |